POU2AF1 and Miyoshi myopathy: Using data from the DepMap project,36,37 we confirmedthat POU2AF1 is selectively indispensable for the growth of DLBCL and multiplemyeloma (MM) cells but not essential in other cancer types (Figure 4A).